Institutional investors purchased a net $737.8 thousand shares of ILMN during the quarter ended September 2014 and now own 96.28% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAILLIE GIFFORD & CO. Bought 1.1 Million shares of Illumina Inc
CHURCHILL MANAGEMENT CORP. Bought 51.4 Thousand shares of Illumina Inc